Envestnet Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$590M Buy
6,812,832
+1,639,219
+32% +$157M 0.16% 110
2025
Q4
$497M Sell
5,173,613
-521,214
-9% -$50.6M 0.15% 113
2025
Q3
$542M Buy
5,694,827
+272,938
+5% +$25.1M 0.16% 109
2025
Q2
$473M Buy
5,421,889
+152,823
+3% +$13M 0.14% 129
2025
Q1
$473M Buy
5,269,066
+881,640
+20% +$78.9M 0.15% 119
2024
Q4
$350M Buy
4,387,426
+232,277
+6% +$20.1M 0.11% 161
2024
Q3
$374M Sell
4,155,149
-202,508
-5% -$17M 0.12% 154
2024
Q2
$343M Sell
4,357,657
-50,568
-1% -$4.15M 0.12% 158
2024
Q1
$384M Sell
4,408,225
-14,681
-0.3% -$1.25M 0.14% 132
2023
Q4
$364M Sell
4,422,906
-758,360
-15% -$57.8M 0.15% 122
2023
Q3
$406M Buy
5,181,266
+1,199,639
+30% +$100M 0.19% 104
2023
Q2
$351M Buy
3,981,627
+246,874
+7% +$21.3M 0.16% 104
2023
Q1
$301M Buy
3,734,753
+512,433
+16% +$41.8M 0.14% 119
2022
Q4
$250M Buy
3,222,320
+37,791
+1% +$3.06M 0.13% 140
2022
Q3
$257M Buy
3,184,529
+211,622
+7% +$19M 0.15% 119
2022
Q2
$267M Buy
2,972,907
+133,036
+5% +$13.5M 0.15% 124
2022
Q1
$315M Buy
2,839,871
+39,242
+1% +$4.15M 0.16% 107
2021
Q4
$290M Buy
2,800,629
+86,067
+3% +$9.97M 0.14% 128
2021
Q3
$340M Buy
2,714,562
+155,558
+6% +$20.1M 0.19% 95
2021
Q2
$318M Sell
2,559,004
-200,075
-7% -$25.1M 0.18% 103
2021
Q1
$326M Buy
2,759,079
+577,332
+26% +$67.7M 0.21% 85
2020
Q4
$256M Sell
2,181,747
-1,188
-0.1% -$131K 0.19% 83
2020
Q3
$227M Sell
2,182,935
-90,149
-4% -$9.05M 0.2% 81
2020
Q2
$208M Buy
2,273,084
+204,323
+10% +$19.6M 0.2% 87
2020
Q1
$187M Buy
2,068,761
+264,498
+15% +$28.1M 0.22% 76
2019
Q4
$205M Buy
1,804,263
+159,382
+10% +$17.5M 0.22% 75
2019
Q3
$179M Buy
1,644,881
+62,042
+4% +$6.47M 0.2% 88
2019
Q2
$154M Buy
1,582,839
+89,792
+6% +$8.2M 0.19% 82
2019
Q1
$136M Buy
1,493,047
+411,284
+38% +$36.8M 0.19% 85
2018
Q4
$98.4M Buy
1,081,763
+795,643
+278% +$74.4M 0.15% 104
2018
Q3
$28.1M Sell
286,120
-117,695
-29% -$10.9M 0.05% 140
2018
Q2
$34.6M Buy
403,815
+229,100
+131% +$19.1M 0.08% 121
2018
Q1
$14M Sell
174,715
-112,029
-39% -$9.24M 0.04% 174
2017
Q4
$23.2M Buy
286,744
+3,824
+1% +$306K 0.05% 206
2017
Q3
$22M Buy
282,920
+3,619
+1% +$300K 0.05% 198
2017
Q2
$24.8M Buy
279,301
+39,961
+17% +$3.37M 0.07% 167
2017
Q1
$19.3M Buy
239,340
+22,162
+10% +$1.73M 0.06% 209
2016
Q4
$15.5M Sell
217,178
-39,915
-16% -$3.14M 0.06% 245
2016
Q3
$22.2M Sell
257,093
-42,311
-14% -$3.69M 0.09% 177
2016
Q2
$26M Sell
299,404
-26,872
-8% -$2.17M 0.1% 168
2016
Q1
$24.5M Buy
326,276
+19,191
+6% +$1.45M 0.11% 165
2015
Q4
$23.6M Buy
307,085
+3,193
+1% +$240K 0.11% 172
2015
Q3
$20.3M Sell
303,892
-22,961
-7% -$1.69M 0.1% 175
2015
Q2
$24.2M Buy
+326,853
New +$25M 0.12% 176
2014
Q4
Sell
-27,218
Closed -$1.69M 2635
2014
Q3
$1.69M Buy
27,218
+1,968
+8% +$125K 0.02% 434
2014
Q2
$1.61M Buy
25,250
+4,724
+23% +$287K 0.02% 410
2014
Q1
$1.26M Sell
20,526
-10,998
-35% -$641K 0.01% 396
2013
Q4
$1.81M Buy
31,524
+2,541
+9% +$144K 0.02% 320
2013
Q3
$1.54M Buy
28,983
+3,170
+12% +$171K 0.02% 322
2013
Q2
$1.33M Buy
+25,813
New +$1.28M 0.02% 353

Other funds holding MDT

Envestnet Asset Management's MDT Position: Q1 2026 in Review

Envestnet Asset Management increased its Medtronic (MDT) stake by 32% in Q1 2026, buying an estimated $157M and bringing the position to 6,812,832 shares worth $590M. The position accounts for 0.16% of the portfolio, ranked #110.

Envestnet Asset Management first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Envestnet Asset Management held 6,812,832 shares of Medtronic worth $590M as of Q1 2026.
  • Envestnet Asset Management bought 1,639,219 Medtronic shares in Q1 2026, an estimated $157M.
  • Medtronic made up 0.16% of Envestnet Asset Management's portfolio in Q1 2026, its #110 holding.
  • Envestnet Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.